BofA

Travis Steed

Q: How accurate are Travis Steed's stock ratings?

About 56% of Travis's ratings were profitable over a one-year hold, with an average return of +2.7% per rating, measured by 13Foresight from historical prices.

Q: How is Travis ranked?

Travis Steed is ranked #307 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Bank of America Securities

Wall Street Analyst

★★★★★

#307

on 13Foresight · ranked by our own returns

55%

Success Rate

+2.1%

Average Return

71 of 130 calls profitable · -96.6% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 55% of Travis Steed's ratings turned a profit when each position was held for 2 year — averaging +2.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

173 Buy 77 Hold 22 Sell

Travis's Stock Coverage 41 ratings · 2026-09-20

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	2-Yr Return	vs S&P 500 ⓘ
MOBI Mobia Medical, Inc.	Sep 17, 2026	BUY	Strong Buy +96.9% avg upside 4 analysts	$16.00 51.73% Upside	-2.9%	·
SYK Stryker	Sep 15, 2026	BUY	Strong Buy +33.4% avg upside 37 analysts	$380.00 38.13% Upside	-2.3%	·
BBNX Beta Bionics, Inc.	Sep 14, 2026	HOLD	Strong Buy +4.2% avg upside 15 analysts	$20.00 8.63% Downside	+26.2%	·
GEHC GE Healthcare Technologies Inc	Sep 14, 2026	HOLD	Strong Buy +28.1% avg upside 22 analysts	$74.00 15.32% Upside	-0.2%	·
MDT Medtronic	Sep 14, 2026	BUY	Buy +9.1% avg upside 38 analysts	$110.00 19.40% Upside	-1.6%	·
ISRG Intuitive Surgical	Sep 14, 2026	BUY	Strong Buy +21.9% avg upside 36 analysts	$470.00 19.49% Upside	+4.1%	·
BSX Boston Scientific	Sep 14, 2026	BUY	Strong Buy +55.2% avg upside 38 analysts	$54.00 24.66% Upside	-3.8%	·
KMTS Kestra Medical Technologies Ltd.	Sep 14, 2026	BUY	Strong Buy +15.6% avg upside 9 analysts	$30.00 22.85% Upside	+1.5%	·
COO Cooper Co	Sep 10, 2026	HOLD	Buy +122.2% avg upside 21 analysts	$65.00 17.52% Upside	+0.3%	·
ZBH Zimmer Biomet Holdings	Sep 08, 2026	HOLD	Buy +20.5% avg upside 38 analysts	$110.00 15.34% Upside	+1.2%	·
MMED MiniMed Group, Inc.	Sep 01, 2026	BUY	Strong Buy +13.3% avg upside 14 analysts	$28.00 28.40% Upside	-2.8%	·
BDX Becton Dickinson	Aug 30, 2026	HOLD	Buy +8.9% avg upside 25 analysts	$200.00 10.50% Upside	-2.2%	·
ABT Abbott Laboratories	Aug 20, 2026	BUY	Strong Buy +13.7% avg upside 36 analysts	$115.00 12.11% Upside	-9.5%	·
GMED Globus Medical	Aug 19, 2026	BUY	Strong Buy +25.2% avg upside 24 analysts	$106.00 43.04% Upside	-14.8%	·
HAE Haemonetics	Aug 18, 2026	BUY	Strong Buy -21.5% avg upside 18 analysts	$120.00 10.76% Upside	+3.6%	·
CARL Carlsmed, Inc.	Aug 13, 2026	BUY	Strong Buy +20.6% avg upside 6 analysts	—	+5.3%	·
BAX Baxter International	Aug 11, 2026	HOLD	Buy +46.8% avg upside 23 analysts	$28.00 22.77% Upside	-16.6%	·
CBLL Ceribell, Inc.	Aug 11, 2026	BUY	Strong Buy +4.7% avg upside 8 analysts	—	+14.2%	·
SOLV Solventum Corporation	Aug 11, 2026	HOLD	Buy +2.9% avg upside 16 analysts	$95.00 6.84% Upside	+5.8%	·
EMBC Embecta Corporation	Aug 10, 2026	SELL	Sell +89.0% avg upside 5 analysts	—	-6.2%	·
TNDM Tandem Diabetes Care	Aug 07, 2026	HOLD	Buy +89.2% avg upside 29 analysts	$25.00 48.21% Upside	-23.5%	·
TFX Teleflex	Aug 07, 2026	HOLD	Buy +51.1% avg upside 20 analysts	—	-3.5%	·
RXST RxSight	Aug 05, 2026	SELL	Hold +75.5% avg upside 13 analysts	$6.50 24.92% Upside	+17.3%	·
SIBN SI-Bone	Aug 04, 2026	BUY	Strong Buy +43.4% avg upside 18 analysts	—	+0.6%	·
INSP Inspire Medical Systems	Aug 04, 2026	SELL	Buy +10.9% avg upside 21 analysts	$45.00 41.41% Downside	-16.3%	·
MMSI Merit Medical Systems	Jul 31, 2026	HOLD	Strong Buy +15.7% avg upside 15 analysts	—	+0.4%	·
DXCM Dexcom	Jul 31, 2026	BUY	Strong Buy +19.0% avg upside 32 analysts	—	-0.5%	·
CNMD Conmed	Jul 30, 2026	SELL	Hold +43.3% avg upside 12 analysts	—	+3.3%	·
BLCO Bausch + Lomb Corporation	Jul 30, 2026	SELL	Buy +19.7% avg upside 20 analysts	—	+1.3%	·
EW Edwards Lifesciences	Jul 21, 2026	BUY	Strong Buy +13.9% avg upside 34 analysts	$100.00 13.36% Upside	+5.1%	·
PODD Insulet	Jun 23, 2026	BUY	Strong Buy +54.6% avg upside 32 analysts	$208.00 47.94% Upside	-2.3%	·
IART Integra Lifesciences	May 14, 2026	SELL	Buy +185.2% avg upside 21 analysts	—	-8.3%	·
PEN Penumbra	Jan 15, 2026	BUY	Buy +4.0% avg upside 23 analysts	—	-9.0%	·
PRCT PROCEPT BioRobotics	Nov 05, 2025	BUY	Buy +65.6% avg upside 17 analysts	—	-33.5%	·
ITGR Integer Holdings	Oct 24, 2025	HOLD	Buy -19.7% avg upside 16 analysts	$87.00 31.13% Downside	+72.8%	·
OM Outset Medical	May 13, 2024	SELL	Buy +430.6% avg upside 8 analysts	$3.00 4.83% Downside	+91.6%	·
LUNG Pulmonx	Sep 29, 2023	HOLD	Buy +251.1% avg upside 9 analysts	—	-84.0%	·
DXC DXC Technology	Jan 06, 2021	SELL	Hold +151.9% avg upside 22 analysts	$24.00 122.59% Upside	-6.5%	·
LNTH Lantheus	Sep 27, 2017	BUY	Buy -19.5% avg upside 21 analysts	$22.00 78.10% Downside	+44.3%	·
AXGN AxoGen	Sep 25, 2017	BUY	Strong Buy -20.6% avg upside 21 analysts	$18.00 59.28% Downside	-26.6%	·
VRAYQ Viewray	Aug 07, 2017	BUY	Strong Buy +558333233.3% avg upside 12 analysts	—	·	·

🔒 36 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Travis Steed — Frequently Asked Questions

How accurate are Travis Steed's stock ratings?

Based on the calls 13Foresight could measure, about 56% of Travis's ratings were profitable over a one-year hold, with an average return of +2.7% per rating, or -96.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Travis ranked on 13Foresight?

Travis Steed is currently ranked #307 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Travis cover?

Travis most recently has ratings on MOBI, SYK, BBNX, GEHC, MDT, ISRG, BSX, KMTS, COO, ZBH, MMED, BDX and 29 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Travis Steed

Rating Distribution

Welcome to 13Foresight!